SCHEMBL8391019

SCHEMBL8391019

COc1ccc(C(CN=S(=O)=O)C(=O)NC2CCCCC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 2/20 0.51
▸ YAP1 P46937 4/20 0.51
▸ TEAD4 Q15561 4/20 0.51
▸ CYP3A4 P08684 2/20 0.51
▸ CYP2D6 P10635 2/20 0.51
▸ CYP2C19 P33261 2/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ TSHR P16473 1/20 0.50
▸ HTT P42858 2/20 0.48
▸ MAPT P10636 3/20 0.48
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ EPHX1 P07099 1/20 0.48
▸ TP53 P04637 1/20 0.48
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8339597 0.76 KMT2A (0.37) EPHX2YAP1TEAD4MAPK1MAPT
SCHEMBL7038426 0.75 RAB9A (0.57) EPHX2YAP1TEAD4CYP3A4CYP2D6
SCHEMBL16797442 0.74 ALDH1A1 (0.76) EPHX2YAP1TEAD4CYP3A4CYP2D6
SCHEMBL8336540 0.71 CNR2 (0.40) ALDH1A1KMT2A
SCHEMBL27691760 0.70 EPHX1 (0.50) EPHX2ALDH1A1TSHRRAB9ASMN1; SMN2
SCHEMBL10378518 0.70 EPHX1 (0.50) EPHX2ALDH1A1TSHRRAB9ASMN1; SMN2
SCHEMBL578174 0.70 TSHR (0.59) EPHX2CYP3A4CYP2C19TSHRNPC1
SCHEMBL5325204 0.70 CCR8 (0.51) YAP1TEAD4ALDH1A1TSHRMAPT
SCHEMBL8335851 0.69 CNR2 (0.38) CYP3A4CYP2C19ALDH1A1HTTCYP1A2
SCHEMBL8338167 0.69 HPGD (0.39) MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback